This is supported by observations in TRAMP-C1 allografts versus MyC-CaP; a greater CD45+ cell infiltrate at baseline and following RT; RT-induced altered expression of immune-related genes on NanoString; and reduced tumour growth rate. This evidence concerns the gene PTPRC and neoplasm.